Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLAC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929709 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IKZF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FICD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RORB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KRT16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORAI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMCR8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC5AC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM65B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLRX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC90768 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on